Rheumatology Resources and Support

J&J withMe in your country

The Immune System and Immune-mediated inflammatory diseases

The immune system is your body’s defence against disease and pathogens. In immune-mediated inflammatory diseases, the immune system wrongly attacks its own tissues and causes inflammation, pain, and can result in loss of function.
Nearly 1 in 10 people in Europe are living with an immune-mediated inflammatory disease.
Living with an immune-mediated inflammatory disease has a similar impact on psychological and physical functioning to cancer, heart disease and hypertension.

Johnson & Johnson and Rheumatological Diseases

Johnson & Johnson’s worldwide leadership in immunology has been established from a 30-year heritage of innovation and scientific breakthroughs. For over three decades, we have been a world leader in the development of biologic treatments that have modified the imbalance in patients’ immune systems and have transformed their lives.

We foster active collaborations with academia, emerging companies, patients, and patient groups to accelerate innovation and achieve our shared goals in tackling immune-mediated disease.

Explore our Disease Areas

A man and a woman doing yoga with eyes closed

Rheumatoid Arthritis

a woman with ear plugs in and clicking on her a watch

Axial Spondyloarthritis

Psoriatic Arthritis

References

[1]

NHS. Chronic Lymphocytic Leukaemia – Overview. Available at: https://www.nhs.uk/conditions/chronic-lymphocytic-leukaemia/. Last accessed: February 2025.

[2]

Macmillan Cancer Support. Chronic lymphocytic leukaemia (CLL). Available at: https://www.macmillan.org.uk/cancer-information-and-support/leukaemia/chronic-lymphocytic-leukaemia-cll. Last accessed: February 2025.

[3]

Leukaemia Care. Chronic Lymphocytic Leukaemia (CLL). Available at: https://www.leukaemiacare.org.uk/support-and-information/information-about-blood-cancer/blood-cancer-information/leukaemia/chronic-lymphocytic-leukaemia/. Last accessed: February 2025.

[4]

National Cancer Insititute. Definition of Chemotherapy. Available at: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemotherapy. Last accessed: February 2025.

[5]

Cancer Research UK. Treatment for chronic lymphocytic leukaemia (CLL). Available at: https://www.cancerresearchuk.org/about-cancer/chronic-lymphocytic-leukaemia-cll/treatment/how-you-have. Last accessed: January 2025.

[6]

American Cancer Society. Available at: https://www.cancer.org/cancer/managing-cancer/treatment-types/targeted-therapy. Last accessed: January 2025.

[7]

Macmillan Cancer Support. Targeted therapy for chronic lymphocytic leukaemia (CLL). Available at: https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/targeted-therapies-for-cll. Last accessed: February 2025.

[8]

American Cancer Society. Typical Treatment of Chronic Lymphocytic Leukemia. Available at: https://www.cancer.org/cancer/chronic-lymphocytic-leukemia/treating/treatment-by-risk-group.html. Last accessed: February 2025.

[9]

[10]

National Institute for Health and Care Excellence. BNF: Antifungals, systemic use. Available at: https://bnf.nice.org.uk/treatment-summary/antifungals-systemic-use.html. Last accessed: February 2025.

[11]

Macmillan Cancer Support. G-CSF (Granulocyte-colony stimulating factor). Available at: https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/g-csf. Last accessed: February 2025.

[12]

Cancer Research UK. Survival for chronic lymphocytic leukaemia (CLL). Available at: https://www.cancerresearchuk.org/about-cancer/chronic-lymphocytic-leukaemia-cll/survival. Last accessed: April 2025.

Get In Touch